You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cytochrome P-450 CYP3A Inhibitors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Human Immunodeficiency Virus Type 1 (HIV-1) Infection Trial (Vesatolimod, Cobicistat, Voriconazole)

Not yet recruiting
  • Human Immunodeficiency Virus Type 1 (HIV-1) Infection
  • (no location specified)
Jul 11, 2022

HIV Trial in Baltimore (VH4524184, Midazolam, Placebo)

Recruiting
  • HIV Infections
  • Baltimore, Maryland
    GSK Investigational Site
Jan 11, 2023

Parkinson Disease Trial in Madison (Tavapadon, Carbamazepine)

Active, not recruiting
  • Parkinson Disease
  • Madison, Wisconsin
    Madison, Wisconsin
Jan 13, 2023

Drug Interactions Trial in Austin (CYP450 Cocktail and Transporter Substrates with Pacritinib, Part 2 -Group A Bosentan 125 mg

Recruiting
  • Drug Interactions
  • CYP450 Cocktail and Transporter Substrates with Pacritinib
  • +2 more
  • Austin, Texas
    PPD - Austin Research Unit
Jan 13, 2023

Liver Cirrhosis Trial (Caffeine, Warfarin sodium, Omeprazole)

Not yet recruiting
  • Liver Cirrhosis
  • (no location specified)
Feb 14, 2023

Atopic Dermatitis Trial (Caffeine, Metoprolol, Midazolam)

Not yet recruiting
  • Atopic Dermatitis
  • Caffeine
  • +6 more
  • (no location specified)
May 26, 2023

Drug-drug Interactions Trial in DeLand (napabucasin, cytochrome P450 (CYP450) probe drugs or BCRP transporter substrate)

Completed
  • Drug-drug Interactions
  • napabucasin
  • cytochrome P450 (CYP450) probe drugs or BCRP transporter substrate
  • DeLand, Florida
    Accel Research Sites
Apr 4, 2022

Drug Intolerance, Cytochrome P450 CYP2D6 Enzyme Deficiency, Drug Effect Trial in Geneva (Pupillometry)

Terminated
  • Drug Intolerance
  • +2 more
  • Pupillometry
  • Geneva, Switzerland
    Geneva University Hospitals, Geneva, Switzerland
Nov 24, 2022

Atopic Dermatitis Trial in Bulgaria, United States (Nemolizumab, CYP 450 Substrates)

Recruiting
  • Atopic Dermatitis
  • North Hollywood, California
  • +6 more
Nov 29, 2022

Pharmacologic Action Trial in Silver Spring (Primaquine)

Completed
  • Pharmacologic Action
  • Silver Spring, Maryland
    WRAIR
Oct 18, 2021

Antipsychotic Induced Weight Gain, Non-alcoholic Steatohepatitis (NASH) Trial in Miami (Miricorilant, Fluvoxamine)

Recruiting
  • Antipsychotic Induced Weight Gain
  • Non-alcoholic Steatohepatitis (NASH)
  • Miami, Florida
    Site 01
Feb 3, 2023

Healthy Trial in Geneva (Dextromethorphan 5 MG, Paroxetine 10Mg Tablet, Paroxetine 20Mg Tablet)

Completed
  • Healthy
  • Dextromethorphan 5 MG
  • +2 more
  • Geneva, Switzerland
    HUG
Jan 3, 2022

Ulcerative Colitis (UC), Crohn's Disease Trial in Germany, Israel, United States (Risankizumab, Cytochrome P450 (CYP)

Completed
  • Ulcerative Colitis (UC)
  • Crohn's Disease
  • Coronado, California
  • +5 more
Oct 20, 2022

B-cell Malignancies Trial in Australia (Zanubrutinib, Fluconazole, Diltiazem)

Completed
  • B-cell Malignancies
  • Concord, New South Wales, Australia
  • +6 more
Jul 18, 2022

Healthy Participants Trial in Dallas (MYK-224, Itraconazole, Verapamil)

Recruiting
  • Healthy Participants
  • Dallas, Texas
    Labcorp CRU
Jun 9, 2022

Healthy Trial (Sildenafil, Erythromycin, Itraconazole)

Completed
  • Healthy
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Oct 25, 2022

Relapsed or Refractory Lymphoma Trial in Austin (HMPL-523, Itraconazole, Rifampin)

Active, not recruiting
  • Relapsed or Refractory Lymphoma
  • Austin, Texas
    PPD Austin
Jan 31, 2023

Healthy Volunteers Trial in Berlin (Zoliflodacin Patheon)

Recruiting
  • Healthy Volunteers
  • Zoliflodacin Patheon
  • Berlin, Germany
    Parexel Early Phase Clinical Unit
Nov 22, 2022

Healthy Trial in Salt Lake City (BMS-986165, Fluvoxamine)

Completed
  • Healthy
  • Salt Lake City, Utah
    ICON Plc (PRA Health Sciences)
Nov 9, 2021

Drug Interaction Trial in Uppsala (Drug Drug Interaction)

Recruiting
  • Drug Interaction
  • Drug Drug Interaction
  • Uppsala, Sweden
    CTC Clinical Trial Consultants AB
Apr 13, 2023

DAPHNE Study: Direct Anticoagulant PHarmacogeNEtic

Completed
  • Anticoagulants and Bleeding Disorders
  • CYP3A4/5 and P-gp phenotyping
  • CYP3A4/5 and P-gp genotyping
  • Geneva, Switzerland
    HUG
Sep 29, 2021

Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in Worldwide (acapatamab, Pembrolizumab, Etanercept)

Active, not recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Prostate Cancer
  • Campbell, California
  • +29 more
Dec 6, 2022

Healthy Trial in Dallas (LY3871801, Methotrexate, Warfarin)

Recruiting
  • Healthy
  • Dallas, Texas
    Covance Dallas
Dec 26, 2022

Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant, Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant Trial in Bauru

Completed
  • Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant
  • Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant
  • Bauru, São Paulo, Brazil
    Bauru School of Dentistry/USP
Nov 2, 2020

Drug-Drug Interaction Trial in Porto (ITF2357 Givinostat 10mg/mL, Midazolam 1Mg/Ml (Pf) Inj Syringe 5Ml, Midazolam Oral Liquid

Completed
  • Drug-Drug Interaction
  • ITF2357 Givinostat 10mg/mL
  • +4 more
  • Porto, Portugal
    Hospital da Prelada, 3rd Floor & East Wing 4th Floor Rua Sarment
Aug 4, 2022